We are live on
!
Find out more
Arbutus Biopharma
ABUS
ABUS
49 hedge funds and large institutions have $65.5M invested in Arbutus Biopharma in 2014 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 15 increasing their positions, 10 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
137% more call options, than puts
Call options by funds: $8.69M | Put options by funds: $3.66M
50% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 10
17% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 18
2% more funds holding
Funds holding: 48 → 49 (+1)
35% less capital invested
Capital invested by funds: $100M → $65.5M (-$34.9M)
Holders
49
Holders Change
+1
Holders Change %
+2.08%
% of All Funds
1.31%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
21
Increased
15
Reduced
10
Closed
18
Calls
$8.69M
Puts
$3.66M
Net Calls
+$5.03M
Net Calls Change
+$12.5M
Top Buyers
| 1 |
Franklin Resources
San Mateo,
California
|
+$10.2M |
| 2 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$3.02M |
| 3 |
SIA
Sit Investment Associates
Minneapolis,
Minnesota
|
+$1.64M |
| 4 |
Citigroup
New York
|
+$1.51M |
| 5 |
B
Bailard
Foster City,
California
|
+$1.38M |
Top Sellers
| 1 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
-$7.93M |
| 2 |
Morgan Stanley
New York
|
-$7.14M |
| 3 |
BG
BlackRock Group
London,
United Kingdom
|
-$2.41M |
| 4 |
Tudor Investment Corp
Stamford,
Connecticut
|
-$2.11M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$2.08M |
